There is a newly FDA approved, non-opioid drug on the market for those who suffer with osteoarthritic knee pain. Researchers and scientists are hailing its arrival as a non-surgical advancement in the struggle to relieve a growing number of patients, both old and young, from the debilitating effects of chronic knee pain. Successfully conducted studies confirm these findings, a boon to both patients and practitioners. The drug, commercially known as ZILRETTA, will be marketed this Fall. Administered by injection this time-released medicine promises real relief for extended periods.